SpotitEarly

SpotitEarly is a United States based company with 15 employees dedicated to transforming cancer pre-screening. They offer a revolutionary AI-powered test that can detect multiple types of cancer from a simple breath sample obtained at home. The company's core product is an off-the-shelf, affordable test designed to overcome common barriers to regular cancer screening. SpotitEarly's test allows for easy, self-administered sample collection, making it accessible to a wider range of individuals regardless of their location or healthcare access. Powered by advanced technology, SpotitEarly's breath analysis test boasts an impressive 94% accuracy rate in detecting cancerous Volatile Organic Compounds (VOCs) in exhaled breath. This high accuracy, even in early-stage cancer detection, significantly improves treatment outcomes and increases survival rates. SpotitEarly can be reached at spotitearly.com for more information about their innovative cancer pre-screening solutions.